ACADIA Pharmaceuticals Inc Announces Positive Top-line Results Call Transcript - Thomson StreetEvents

ACADIA Pharmaceuticals Inc Announces Positive Top-line Results Call Transcript

ACADIA Pharmaceuticals Inc Announces Positive Top-line Results Call Transcript - Thomson StreetEvents
ACADIA Pharmaceuticals Inc Announces Positive Top-line Results Call Transcript
Published Dec 06, 2021
21 pages (12850 words) — Published Dec 06, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ACAD.OQ conference call or presentation 6-Dec-21 9:30pm GMT

  
Brief Excerpt:

...Operator Good day, ladies and gentlemen, and welcome to ACADIA Pharmaceuticals conference call. My name is Towanda, and I will be your coordinator for today. (Operator Instructions) I would now like to turn the presentation over to Mark Johnson, Vice President of Investor Relations of ACADIA. You may proceed. Mark C. Johnson ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
ACADIA Pharmaceuticals Inc
Ticker
ACAD.OQ
Time
9:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Gregory James Renza - RBC Capital Markets, Research Division - Analyst : Steve and team, let me add my congratulations on the data as well. Steve, just a quick one for me. Perhaps if you don't mind just reminding us of the arrangement you have with Neuren Pharmaceuticals and those economic terms there associated with trofinetide. And perhaps within that, if you could just confirm how the potential PRV that you cite in the press release and in the call would be potentially shared across both you and Neuren with that market value breakdown?

Table Of Contents

ACADIA Pharmaceuticals Inc at Needham Neuroscience Forum (Virtual) Transcript – 2022-03-16 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 16-Mar-22 7:20pm GMT

ACADIA Pharmaceuticals Inc at Cowen Health Care Conference (Virtual) Transcript – 2022-03-09 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 9-Mar-22 7:50pm GMT

ACADIA Pharmaceuticals Inc Q4 2021 Earnings Call Transcript – 2022-02-28 – US$ 54.00 – Edited Transcript of ACAD.OQ earnings conference call or presentation 28-Feb-22 9:30pm GMT

ACADIA Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript – 2022-01-11 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 11-Jan-22 3:30pm GMT

ACADIA Pharmaceuticals Inc Resubmission of sNDA for Pimavanserin for the Treatment of ADP Call Transcript – 2021-12-20 – US$ 54.00 – Edited Transcript of ACAD.OQ conference call or presentation 20-Dec-21 9:30pm GMT

ACADIA Pharmaceuticals Inc Q3 2021 Earnings Call Transcript – 2021-11-08 – US$ 54.00 – Edited Transcript of ACAD.OQ earnings conference call or presentation 8-Nov-21 9:30pm GMT

ACADIA Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2021-09-13 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 13-Sep-21 3:45pm GMT

ACADIA Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) Transcript – 2021-09-10 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 10-Sep-21 3:35pm GMT

ACADIA Pharmaceuticals Inc Q2 2021 Earnings Call Transcript – 2021-08-04 – US$ 54.00 – Edited Transcript of ACAD.OQ earnings conference call or presentation 4-Aug-21 8:30pm GMT

ACADIA Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript – 2021-06-08 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 8-Jun-21 6:10pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "ACADIA Pharmaceuticals Inc Announces Positive Top-line Results Call Transcript" Dec 06, 2021. Alacra Store. May 12, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/ACADIA-Pharmaceuticals-Inc-Announces-Positive-Top-line-Results-Call-T15067810>
  
APA:
Thomson StreetEvents. (2021). ACADIA Pharmaceuticals Inc Announces Positive Top-line Results Call Transcript Dec 06, 2021. New York, NY: Alacra Store. Retrieved May 12, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/ACADIA-Pharmaceuticals-Inc-Announces-Positive-Top-line-Results-Call-T15067810>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.